We are live on
!
Find out more
MP
Mangrove Partners Portfolio holdings
AUM
$1.24B
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+2.19%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.12B
AUM Growth
+$146M
(+15%)
Cap. Flow
-$6.04M
Cap. Flow
% of AUM
-0.54%
Top 10 Holdings %
Top 10 Hldgs %
16.93%
Holding
462
New
136
Increased
57
Reduced
41
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$15M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$10.6M |
| 3 |
Jackson Financial
JXN
|
+$10.4M |
| 4 |
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
|
+$9.86M |
| 5 |
Travere Therapeutics
TVTX
|
+$6.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$32.2M |
| 2 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$12.8M |
| 3 |
Bath & Body Works
BBWI
|
+$11M |
| 4 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$9.94M |
| 5 |
Liberty Media Series A
FWONA
|
+$9.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.94% |
| 2 | Healthcare | 10.97% |
| 3 | Technology | 7.15% |
| 4 | Communication Services | 3.95% |
| 5 | Industrials | 3.69% |
Similar funds
GX
HCA
CA
WTA
NHAS
FLII
CCA
IC
Mangrove Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Mangrove Partners held 462 positions worth $1.12B, up 15% from $971M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Mangrove Partners's Q3 2021 filing shows 136 new, 57 increased, 41 reduced and 111 closed positions. Its largest new stake was Biogen: 45,872 shares worth $13M. The largest sale was Macquarie Infrastructure Holdings, LLC, an estimated $32.2M.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 37% a quarter earlier, followed by Healthcare and Technology.
- Mangrove Partners's largest Q3 2021 buy was Biogen: 45,872 shares worth $13M.
- Mangrove Partners added most to Travere Therapeutics in Q3 2021, an estimated $6.57M increase.
- Mangrove Partners's biggest Q3 2021 reduction was Pershing Square Tontine Holdings, Ltd., cutting an estimated $12.8M.
- Mangrove Partners fully exited Macquarie Infrastructure Holdings, LLC in Q3 2021, selling an estimated $32.2M.
- Mangrove Partners's ten largest holdings make up 17% of its $1.12B portfolio in Q3 2021.
- Mangrove Partners opened 136 new positions and closed 111 in Q3 2021.
- Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $1.12B.
Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.